Brief: Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2023 Financial Results And Provides Business Update
10/02/2023 22:05
Citius Pharmaceuticals Inc CTXR.O :
* CITIUS PHARMACEUTICALS, INC. REPORTS FISCAL FIRST QUARTER
2023
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CITIUS PHARMACEUTICALS INC Q1 LOSS PER SHARE $0.02
* CITIUS PHARMACEUTICALS INC - $36.9 MILLION IN CASH AND
CASH
EQUIVALENTS AS OF DECEMBER 31, 2022; RUNWAY THROUGH FEBRUARY
2024
Source text for Eikon: ID:nPn8KdNtYa
Further company coverage: CTXR.O
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules